Phenotypic characterization of first generation Maghrebian migrants with type 2 diabetes. A gender-based comparison with a reference North-Caucasian Belgian cohort

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 2, Issue 2, 2008, Pages 115-124

  Munoko, Thierry N ^a   Hermans, Michel P ^b  

^a UNIVERSITY OF KINSHASA   (Congo)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Diabetes; Ethnicity; Hyperbolic product; Maghreb; Metabolic syndrome

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; AGED; ANTHROPOMETRY; ARTICLE; BELGIUM; BIOCHEMISTRY; BODY FAT; BODY MASS; CAUCASIAN; CELL FUNCTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; DETERIORATION; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; HYPOTHESIS; INSULIN RELEASE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; METABOLIC SYNDROME X; MIGRATION; MOROCCO; NON INSULIN DEPENDENT DIABETES MELLITUS; NORTH AFRICA; PANCREAS ISLET BETA CELL; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL ASPECT; TEACHING HOSPITAL; WAIST CIRCUMFERENCE;

EID: 43049128538     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2008.02.004     Document Type: Article

References (32)

1. United Kingdom Prospective Diabetes Study (UKPDS 12): differences between Asian Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabetic Med 11 (1994) 670-677
2. Carter J.S., Pugh J.A., and Monterosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 125 (1996) 221-232
3. Haffner S.M., Howard G., Mayer E., et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM. The Insulin Resistance Atherosclerosis Study. Diabetes 46 (1997) 63-69
4. United Kingdom Prospective Diabetes Study (UKPDS 55): relationship between ethnicity and glycaemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes. Diabetes Care 24 (2001) 1167-1174
5. Hermans M.P., Dumont C., and Buysschaert M. Clinical, biophysical and biochemical variables from African-heritage subjects with type 2 diabetes. Acta Clin Belg 57 (2002) 134-141
6. Dijkshoorn H., Uitenbroek D.G., and Middelkoop B.J. Prevalence of diabetes mellitus and cardiovascular disease among immigrants from Turkey and Morocco and the indigenous Dutch population [article in Dutch]. Ned Tijdschr Geneeskd 147 (2003) 1362-1366
7. Hermans M.P. Diabetes in ethnic minorities. In: Lefèbvre P., and De Leeuw I. (Eds). Clinical implications of Belgian diabetes research (2004), Belgian Diabetes Study Group 63-66
8. Uitewaal P.J., Manna D.R., Bruijnzeels M.A., Hoes A.W., and Thomas S. Prevalence of type 2 diabetes mellitus, other cardiovascular risk factors, and cardiovascular disease in Turkish and Moroccan immigrants in North West Europe: a systematic review. Prev Med 39 (2004) 1068-1076
9. Selvais P.L., and Hermans M.P. Characterization of type 2 diabetes mellitus in first generation Italian migrants to Belgium. Acta Clin Belg 60 (2005) 362-368
10. Dehout F., Haumont S., Gaham N., Amoussou-Guenou K.D., and Hermans MP. Metabolic syndrome in Bantu subjects with type 2 diabetes from sub-Saharan extraction: prevalence, gender differences and HOMA-hyperbolic product. Diab Metabolic Syndrome: Clin Res Rev 2 (2008) 5-11
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
12. Kyle U.G., Morabia A., Schutz Y., and Pichard C. Sedentarism affects body fat mass index and fat-free mass index in adults aged 18 to 98 years. Nutrition 20 (2004) 255-260
13. Burkhauser R.V., and Cawley J. Beyond BMI: the value of more accurate measures of fatness and obesity in social science research. J Health Econ (2007) [Epub ahead of print]
14. Valdez R., Seidell J.C., Ahn Y.I., and Weiss K.M. A new index of abdominal adiposity as an indicator of risk for cardiovascular disease: a cross-population study. Int J Obes 16 (1992) 77-82
15. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
16. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
17. Rudenski A.S., Hadden D.R., Atkinson A.B., Kennedy L., Matthews D.R., Merrett J.D., et al. Natural history of pancreatic islet B-cell function in Type 2 diabetes mellitus studied over 6 years by Homeostasis Model Assessment. Diabetic Med 5 (1988) 36-41
18. Levy J.C., Matthews D.R., and Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 (1998) 2191-2192
19. Hermans M.P., Levy J., Morris R.J., and Turner R.C. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42 (1999) 678-687
20. Hermans M.P., Levy J., Morris R.J., and Turner R.C. Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48 (1999) 1779-1786
21. Hermans M.P. Diabetic macro- and microvascular disease in type 2 diabetes. Diabetes Vasc Dis Res 4 (2007) S7-S11
22. Preumont V., Hermans M.P., Lebecque P., and Buysschaert M. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with gene CFTR ΔF 508 mutation. Diabetes Care 30 (2007) 1187-1192
23. Kahn S.E., Prigeon R.L., Mc Culloch D.K., Boyko E.J., Berman R.N., Schwartz M.W., et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42 (1993) 1663-1672
24. Bergman R.N., Watanabe R., Rebrin K., Ader M., and Steil G. Toward an integrated phenotype in pre-NIDDM. Diabetic Med 13 (1996) S67-S77
25. Albareda M., Rodríguez-Espinosa J., Murugo M., de Leiva A., and Corcoy R. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 43 (2000) 1507-1511
26. Bagust A., and Beale S. Deteriorating beta-cell function in type 2 diabetes: a long-term model. Q J Med 96 (2003) 281-288
27. Bergman R.N. Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology. Mt Sinai J Med 69 (2002) 280-290
28. Guerrero-Romero F., and Rodriguez-Moran. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus. Eur J Clin Invest 36 (2006) 796-802
29. Bergman R.N. Banting lecture 2006. Orchestration of glucose homestasis. From a small acorn to California oak. Diabetes 56 (2007) 1489-1501
30. Levy J., Atkinson A.B., Bell P.M., McCance D.R., and Hadden D.R. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabetic Med 15 (1998) 290-296
31. Turner R.C., Cull C.A., Frighi V., and Holman R.R. Glycemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281 (1999) 2005-2012
32. Utzschneider K.M., Prigeon R.L., Carr D.B., Hull R.L., Tong J., Shofer J.B., et al. Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. Diabetes Care 29 (2006) 356-362